Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 12 Apr | 916.15 |
-27.50 (-2.91%) |
OPEN
944.65 |
HIGH
949.00 |
LOW
906.00 |
NSE 00:00 | 12 Apr | 915.20 |
-28.50 (-3.02%) |
OPEN
940.70 |
HIGH
949.25 |
LOW
906.00 |
OPEN | 944.65 |
PREVIOUS CLOSE | 943.65 |
VOLUME | 242270 |
52-Week high | 1023.10 |
52-Week low | 393.75 |
P/E | 18.00 |
Mkt Cap.(Rs cr) | 53,677 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Company Information
Aurobindo Pharma Limited (APL) one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy Mr. K.Nityananda Reddy and a small highly committed group of professionals founded it. APL is developing manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives) in...> More
COMPANY INFORMATION | |||||||
Director : | P V Ramprasad Reddy | ||||||
Vice Chairman & Whole Time Dir : | K Nithyananda Reddy | ||||||
Whole-time Director : | M Sivakumaran | ||||||
Whole-time Director : | M Madan Mohan Reddy | ||||||
Independent Director : | M Sitarama Murthy | ||||||
Whole-time Director : | P Sarath Chandra Reddy | ||||||
Chairman & Independent Directo : | K Ragunathan | ||||||
Managing Director : | N Govindarajan | ||||||
Independent Director : | Avnit Bimal Singh | ||||||
Company Secretary : | B Adi Reddy | ||||||
Independent Director : | Savita Mahajan | ||||||
Additional Director : | Girish Paman Vanvari | ||||||
AUDITOR : | B S R & Associates LLP | ||||||
IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
HOUSE NAME : | Indian Private | ||||||
Registered office | |||||||
Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet,Hyderabad,Telangana-500038 | |||||||
Ph : 91-40-23736370 | |||||||
WEBSITE : http://www.aurobindo.com | |||||||
E-mail : info@aurobindo.com/investorgrievances@aurobindo.co |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices